Stephen Clayton Saris, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioma | 9 | 1996 | 3401 | 0.230 |
Why?
|
| Spinal Nerve Roots | 3 | 1988 | 121 | 0.220 |
Why?
|
| Interleukin-2 | 8 | 1992 | 1904 | 0.220 |
Why?
|
| Brain Neoplasms | 12 | 1996 | 8861 | 0.190 |
Why?
|
| Infusions, Intra-Arterial | 3 | 1991 | 234 | 0.180 |
Why?
|
| Carotid Arteries | 3 | 1988 | 950 | 0.120 |
Why?
|
| AIDS Dementia Complex | 1 | 1993 | 154 | 0.100 |
Why?
|
| Counterpulsation | 1 | 1991 | 19 | 0.100 |
Why?
|
| Antipyrine | 2 | 1988 | 40 | 0.100 |
Why?
|
| Stereotaxic Techniques | 2 | 1993 | 536 | 0.100 |
Why?
|
| Boron Compounds | 1 | 1992 | 178 | 0.100 |
Why?
|
| Phenylalanine | 1 | 1992 | 365 | 0.100 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 1992 | 358 | 0.090 |
Why?
|
| Ependymoma | 1 | 1991 | 334 | 0.080 |
Why?
|
| Sciatica | 1 | 1988 | 98 | 0.070 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1991 | 1475 | 0.070 |
Why?
|
| Pain | 3 | 1988 | 4988 | 0.070 |
Why?
|
| Infusion Pumps | 1 | 1987 | 163 | 0.070 |
Why?
|
| Phantom Limb | 1 | 1988 | 91 | 0.070 |
Why?
|
| Astrocytoma | 1 | 1991 | 790 | 0.070 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 1992 | 1038 | 0.070 |
Why?
|
| Perineum | 1 | 1986 | 211 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1991 | 1366 | 0.060 |
Why?
|
| Cushing Syndrome | 1 | 1987 | 249 | 0.060 |
Why?
|
| Cisplatin | 1 | 1991 | 1662 | 0.060 |
Why?
|
| Brain Edema | 1 | 1989 | 617 | 0.060 |
Why?
|
| Ganglia, Spinal | 1 | 1985 | 519 | 0.050 |
Why?
|
| Brain | 6 | 1993 | 26388 | 0.040 |
Why?
|
| Pituitary Neoplasms | 1 | 1987 | 1345 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 3 | 1993 | 20130 | 0.040 |
Why?
|
| Blood-Brain Barrier | 2 | 1996 | 1019 | 0.040 |
Why?
|
| Carbon Radioisotopes | 2 | 1988 | 577 | 0.030 |
Why?
|
| Adenoma | 1 | 1987 | 2174 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 1989 | 1420 | 0.030 |
Why?
|
| Glioblastoma | 1 | 1991 | 3481 | 0.030 |
Why?
|
| Immunotherapy | 1 | 1990 | 4446 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 1992 | 6313 | 0.030 |
Why?
|
| Neutrons | 1 | 1992 | 76 | 0.030 |
Why?
|
| Gliosis | 1 | 1993 | 245 | 0.030 |
Why?
|
| Recombinant Proteins | 3 | 1992 | 6621 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1992 | 191 | 0.020 |
Why?
|
| Killer Cells, Lymphokine-Activated | 1 | 1990 | 42 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 1996 | 13693 | 0.020 |
Why?
|
| Kinetics | 2 | 1988 | 6476 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 1992 | 21833 | 0.020 |
Why?
|
| Rats, Inbred F344 | 3 | 1989 | 862 | 0.020 |
Why?
|
| Sodium Compounds | 1 | 1989 | 30 | 0.020 |
Why?
|
| Postoperative Complications | 3 | 1988 | 15297 | 0.020 |
Why?
|
| Encephalitis | 1 | 1993 | 425 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 1990 | 964 | 0.020 |
Why?
|
| Carotid Artery, Internal | 1 | 1991 | 445 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 1991 | 1144 | 0.020 |
Why?
|
| Lymphocyte Transfusion | 1 | 1989 | 236 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 2 | 1991 | 2732 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 1991 | 895 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1988 | 683 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 1991 | 1423 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 1993 | 971 | 0.020 |
Why?
|
| Sacrococcygeal Region | 1 | 1986 | 52 | 0.020 |
Why?
|
| Putamen | 1 | 1988 | 291 | 0.020 |
Why?
|
| Autoradiography | 1 | 1987 | 745 | 0.020 |
Why?
|
| Animals | 10 | 1992 | 168768 | 0.020 |
Why?
|
| Lumbosacral Region | 1 | 1988 | 310 | 0.020 |
Why?
|
| Orientation | 1 | 1988 | 327 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1988 | 2186 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 1987 | 332 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1989 | 623 | 0.020 |
Why?
|
| Caudate Nucleus | 1 | 1988 | 393 | 0.020 |
Why?
|
| Syringomyelia | 1 | 1986 | 64 | 0.020 |
Why?
|
| Lymphokines | 1 | 1989 | 949 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 1989 | 982 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 1990 | 13104 | 0.020 |
Why?
|
| Urogenital Neoplasms | 1 | 1986 | 137 | 0.020 |
Why?
|
| Diastole | 1 | 1987 | 791 | 0.020 |
Why?
|
| Macaca mulatta | 2 | 1989 | 2377 | 0.020 |
Why?
|
| Mice | 4 | 1992 | 81201 | 0.020 |
Why?
|
| Injections, Intra-Arterial | 1 | 1984 | 193 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1988 | 2327 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1991 | 3207 | 0.010 |
Why?
|
| Rats | 4 | 1989 | 24252 | 0.010 |
Why?
|
| Female | 10 | 1996 | 380193 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 1988 | 838 | 0.010 |
Why?
|
| Drainage | 1 | 1988 | 1142 | 0.010 |
Why?
|
| Up-Regulation | 1 | 1991 | 4222 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1991 | 6366 | 0.010 |
Why?
|
| Karyotyping | 1 | 1984 | 1243 | 0.010 |
Why?
|
| Male | 12 | 1996 | 350115 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1988 | 1406 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1991 | 5974 | 0.010 |
Why?
|
| Biopsy | 1 | 1993 | 6755 | 0.010 |
Why?
|
| Sarcoidosis | 1 | 1986 | 506 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1988 | 1670 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1991 | 4424 | 0.010 |
Why?
|
| Nerve Block | 1 | 1986 | 644 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1984 | 2086 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 1989 | 2133 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1992 | 8642 | 0.010 |
Why?
|
| Adult | 8 | 1996 | 214052 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1992 | 10252 | 0.010 |
Why?
|
| Extremities | 1 | 1985 | 866 | 0.010 |
Why?
|
| Middle Aged | 7 | 1996 | 213390 | 0.010 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1986 | 990 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1993 | 3079 | 0.010 |
Why?
|
| Humans | 13 | 1996 | 744366 | 0.010 |
Why?
|
| Oxygen Radioisotopes | 1 | 1996 | 76 | 0.010 |
Why?
|
| Rubidium Radioisotopes | 1 | 1996 | 85 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 1988 | 39052 | 0.010 |
Why?
|
| Aged | 5 | 1996 | 163288 | 0.010 |
Why?
|
| Permeability | 1 | 1996 | 738 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1996 | 1525 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1986 | 9145 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1990 | 18034 | 0.010 |
Why?
|
| Chromates | 1 | 1989 | 7 | 0.010 |
Why?
|
| Models, Biological | 1 | 1984 | 9584 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1993 | 35425 | 0.000 |
Why?
|
| Cell Count | 1 | 1989 | 1856 | 0.000 |
Why?
|
| Ruthenium | 1 | 1984 | 22 | 0.000 |
Why?
|
| Carotid Artery, External | 1 | 1984 | 38 | 0.000 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 1984 | 85 | 0.000 |
Why?
|
| Ligation | 1 | 1984 | 453 | 0.000 |
Why?
|
| Radioisotopes | 1 | 1984 | 500 | 0.000 |
Why?
|
| Microspheres | 1 | 1984 | 777 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1989 | 2967 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1989 | 5524 | 0.000 |
Why?
|
| Body Weight | 1 | 1984 | 4671 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1989 | 7914 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1989 | 5709 | 0.000 |
Why?
|
| Child | 1 | 1989 | 77709 | 0.000 |
Why?
|
| Adolescent | 1 | 1989 | 85779 | 0.000 |
Why?
|